Replies to post #103713 on Biotech Values

[alertmeipp]

>>Lovenox scripts in graph form

Thanks all for the info.
Nice ramp up.

1 month has passed since the approval. If Teva's is coming, it will be this month. I doubt it. What if FDA actually "reject" it...

will MNTA triple?

[DewDiligence]

NVS/MNTA’s Lovenox=44% of total scripts/46% of new scripts, according to the latest IMS data cited by a report from Cowen this morning.

NVS/MNTA are closing in on the 50% market share one would expect in a “pure” duopoly with pricing parity and unfettered supply.